2018. Long-Term Efficacy of Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: Data from a Pivotal Phase 3 Clinical Trial. SKIN The Journal of Cutaneous Medicine. 2, S1 (Feb. 2018), S9. DOI:https://doi.org/10.25251/skin.2.supp.9.